Coffey County Hospital | |
801 N Fourth Street, Burlington, Kansas 66839 | |
(620) 364-2121 | |
Name | Coffey County Hospital |
---|---|
Type | Critical Access Hospital |
Location | 801 N Fourth Street, Burlington, Kansas |
Ownership | Government - Local |
Emergency Services | Yes |
Medicare ID (CCN) | 171385 |
NPI Number | 1376548370 |
Organization Name | COFFEY COUNTY HOSPITAL |
Doing Business As | COFFEY COUNTY HOSPITAL |
Address | 801 N 4th, Burlington, KS 66839 |
Hospital Type | General Acute Care Hospital |
Phone Number | 620-364-2121 |
News Archive
Five types of pediatric brain cancer were safely and effectively treated in mice by an antibody that causes immune cells to engulf and eat tumors without hurting healthy brain cells, according to a new study by researchers at the Stanford University School of Medicine.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of cancer of the fallopian tube.
Hospitals in the Dallas/Fort Worth area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 25 Dallas/Fort Worth area hospitals along with other critical patient safety and satisfaction information for consumers.
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 12/996,124, a patent which covers the use of cannabinoids for treating glioma.
› Verified 8 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Five types of pediatric brain cancer were safely and effectively treated in mice by an antibody that causes immune cells to engulf and eat tumors without hurting healthy brain cells, according to a new study by researchers at the Stanford University School of Medicine.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of cancer of the fallopian tube.
Hospitals in the Dallas/Fort Worth area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 25 Dallas/Fort Worth area hospitals along with other critical patient safety and satisfaction information for consumers.
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 12/996,124, a patent which covers the use of cannabinoids for treating glioma.
› Verified 8 days ago
Coffey County Hospital Critical Access Hospital Location: 801 N Fourth Street, Burlington, Kansas 66839 Phone: (620) 364-2121 |